PI-103 Hydrochloride
Cat. No.:YN420022
产品名称: | PI-103 Hydrochloride |
CAS No.: | 371935-79-4 |
Chemical Name: | 3-[4-(4-morpholinyl)pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl]-phenol, monohydrochloride |
Synonyms: | PI 103 hydrochloride;PI103 hydrochloride |
分子量: | 384.82 |
分子式: | C₁₉H₁₇ClN₄O₃ |
SMILES: | OC1=CC(C2=NC3=C(OC4=C3C=CC=N4)C(N5CCOCC5)=N2)=CC=C1.[H]Cl |
存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
运输: | Room temperature in continental US; may vary elsewhere. |
产品描述: | PI-103 Hydrochloride 是一种有效的PI3K和mTOR抑制剂,抑制p110α,p110β,p110δ,p110γ,mTORC1和mTORC2,IC50分别为 8 nM,88 nM,48 nM,150 nM,20 nM 和 83 nM。PI-103 Hydrochloride 也可抑制DNA-PK,IC50为 2 nM。PI-103 Hydrochloride 诱导自噬 (autophagy)。 |
IC50和靶点: | [{name:"p110α:2 nM (IC50)"},{name: "p110β:3 nM (IC50)"},{name: "p110δ:3 nM (IC50)"},{name: "p110γ:15 nM (IC50)"},{name: "mTORC1:20 nM (IC50)"},{name: "mTORC2:83 nM (IC50)"},{name: "DNA-PK:23 nM (IC50)"}] |
In Vitro: | |
In Vivo: | |
Clinical Trial: | |
Solvent & Solubility: |
Knight, Z.A., Gonzalez, B., Feldman, M.E., et al.A pharmacological map of the PI3-K family defines a role for p110α in insulin signalingCell125(4),733-747(2006)
Fan, Q.W., Knight, Z.A., Goldenberg, D.D., et al.A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in gliomaCancer Cell9(5),341-349(2006)